Skip to content

The Value of F-18-fluorodeoxyglucose positron emission tomography for detection of metastatic infectious foci complicating Gram-positive bacteremia.

The Value of F-18-fluorodeoxyglucose positron emission tomography for detection of metastatic infectious foci complicating Gram-positive bacteremia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24175
Enrollment
115
Registered
2007-04-11
Start date
2005-11-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

FDG-PET infection bacteremia metastatic infection Staphylococcus aureus Streptococcus species Enterococcus species endocarditis

Interventions

FDG-PET will be performed within 14 days after intiatiation of treatment. The attending physician will be informed of the results of FDG-PET immediately. Special attention will be paid to confirmation

Sponsors

Prof. dr. W.J.G. Oyen Department of Nuclear Medicine Radboud University Nijmegen Medical Centre P.O. Box 9101, 6500 HB Nijmegen The Netherlands T: 31 (0)24 3614048 Prof dr. B.J. Kullberg Department of Internal Medicine Radboud University Nijmegen Medical Centre P.O. Box 9101, 6500 HB Nijmegen The Netherlands T: 31 (0)24 3614763
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients with blood cultures containing one of the following microorganisms: a. S. aureus; b. Streptococcus spp (excluding S. pneumoniae); c. Enterococcus spp. 2. AND at least one of the following risk factors for metastatic infection: a. Community acquired infection; b. Signs of infection for more than 48 hrs before initiation of appropriate treatment; c. Skin lesions or other symptoms or signs pointing to possible metastatic infection; d. Fever lasting for more than72 hrs after initiation of appropriate treatment; e. Positive blood cultures for more than 48 hrs after initiation of appropriate treatment; 3. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years; 2. Polymicrobial infection; 3. Pregnancy; 4. Critically ill patients initially admitted to the ICU department for more than 14 days; 5. Chemotherapeutically induced neutropenia.

Design outcomes

Primary

MeasureTime frame
Relapse rate of infection.

Secondary

MeasureTime frame
1. Attributable mortality; 2. Mortality after relapse; 3. Duration of first admission; 4. Duration of antibiotic treatment; 5. Number of diagnostic procedures performed to confirm metastatic foci, duration of admission due to relapse; 6. Associated costs.

Contacts

Public ContactF.J. Vos

Radboud University Nijmegen Medical Centre, Department of Internal Medicine, 463, P.O. Box 9101

F.Vos@AIG.umcn.nl31 (0)24 3614763

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)